One Dose of HPV Vaccine Could Be Enough

One Dose of HPV Vaccine Could Be Enough

A large-scale clinical trial conducted by the National Cancer Institute found that one dose of an HPV vaccine is just as protective against infection as the traditional 2-dose regimen. The randomized study, which enrolled more than 20,000 girls aged 12 to 16 years, compared the effectiveness of 1 and 2 does of the bivalent Cervarix (GlaxoSmithKline) vaccine and the 9-valent Gardasil 9 (Merck) vaccine. Participants were assigned to receive either dosing regimen, and both groups …

Read More
Protective Effect Against HPV Seen in Vaccinated Generation

Protective Effect Against HPV Seen in Vaccinated Generation

New long-term data shows the human papillomavirus (HPV) vaccine introduced in 2006 to reduce the incidence of cervical cancer in women is having its intended effect. An observational study of 447,845 women in Scotland born between 1988 and 1996 revealed there were no cases of cervical cancer found among those who received the vaccine at age 12 or 13—even if the patient did not receive all 3 of the recommended doses. Those who were immunized …

Read More